Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
538
NCT00467428
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2003
Completion: Sep 30, 2004
NCT00258622
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
Role: Collaborator
Start: Nov 30, 2005
Completion: Feb 28, 2007
NCT00394667
Effect of Tesofensine on Weight Reduction in Patients With Obesity.
Start: Sep 30, 2006
Completion: Sep 30, 2007
NCT00428415
Effect of Tesofensine on Energy Balance in Humans.
Phase: Phase 1/2
Start: Mar 31, 2007
Completion: Dec 31, 2007
NCT00481104
Evaluation of Long Term Safety of Tesofensine in Patients With Obesity
Start: May 31, 2007
Completion: Nov 30, 2008
NCT01023282
Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients
Phase: Phase 1
Start: Nov 30, 2009
Completion: Apr 30, 2011